Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Clinical trial NCT02826603 · COMPLETED
Trial details
- NCT number
- NCT02826603
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2018-07-09
- Enrollment
- 1114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.